One year after receiving CRISPR gene editing therapy at CHOP, a Delaware County baby is thriving, and doctors want to expand ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the top gene therapy stocks to buy according to hedge funds. On February 17, ...

Add Yahoo as a preferred source to see more of our stories on Google. Stanford researchers have developed CRISPR-GPT, an AI-powered copilot that guides gene-editing experiments. (CREDIT: Shutterstock) ...

In the wake of the germline editing controversy, when Chinese scientist He Jianku illegally edited the embryos of human twins ...

ゲノム編集技術「CRISPR」を用いた初の治療法が、このほど英国で承認された。この治療は「CASGEVY」という名称で販売され、1回の治療を意図して設計されたものである。対象となるのは、いずれも遺伝性疾患である鎌状赤血球症と血液疾患「βサラセミア」の ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

CRISPR Therapeutics AG CRSP on Friday reported its fourth-quarter and full-year 2025 financial results, highlighting ...

The past few years have been challenging for the biotech.

A single CRISPR infusion lowered harmful cholesterol and triglycerides by nearly half in early trial results. Although this was a small trial, early safety findings are reassuring. Participants ...

生物医学研究を中心に、遺伝子（ゲノム）を編集する技術である「CRISPR-Cas9」に多くの研究者たちが没頭してきた。専門家たちによると、使うのが簡単で経済的で、効率的であり、いまやその臨床への応用は当然と思われている。 しかしいま ...

CRISPR Therapeutics’ fourth quarter was relatively disappointing. As a biotech start-up still in its infancy though, these ...